Antimicrobial treatment of community-acquired pneumonia in the elderly

Jose A. Velez, Eric M. Mortensen, Antonio R Anzueto, Marcos Restrepo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Community-acquired pneumonia is a clinical diagnosis that has a significant impact on healthcare management around the world, especially in the fastest-growing segment of the population, those aged 65 or older. Early clinical suspicion and prompt empirical antimicrobial therapies are very important in patients with community-acquired pneumonia. This manuscript provides a review of the most recent literature published addressing etiological agents and antimicrobial management of community-acquired pneumonia in persons aged over 65 years with an emphasis on appropriate antimicrobial therapy for hospitalized elderly patients with community-acquired pneumonia.

Original languageEnglish (US)
Pages (from-to)999-1011
Number of pages13
JournalAging Health
Volume2
Issue number6
DOIs
StatePublished - Dec 2006

Fingerprint

Pneumonia
Therapeutics
Anti-Infective Agents
Delivery of Health Care
Population

Keywords

  • Aged
  • Anti-infective agents
  • Antibacterial agents
  • Antibiotics
  • Pneumonia
  • Streptococcus pneumoniae

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Antimicrobial treatment of community-acquired pneumonia in the elderly. / Velez, Jose A.; Mortensen, Eric M.; Anzueto, Antonio R; Restrepo, Marcos.

In: Aging Health, Vol. 2, No. 6, 12.2006, p. 999-1011.

Research output: Contribution to journalArticle

Velez, Jose A. ; Mortensen, Eric M. ; Anzueto, Antonio R ; Restrepo, Marcos. / Antimicrobial treatment of community-acquired pneumonia in the elderly. In: Aging Health. 2006 ; Vol. 2, No. 6. pp. 999-1011.
@article{afc5603fec354d31acbaedae83e599c3,
title = "Antimicrobial treatment of community-acquired pneumonia in the elderly",
abstract = "Community-acquired pneumonia is a clinical diagnosis that has a significant impact on healthcare management around the world, especially in the fastest-growing segment of the population, those aged 65 or older. Early clinical suspicion and prompt empirical antimicrobial therapies are very important in patients with community-acquired pneumonia. This manuscript provides a review of the most recent literature published addressing etiological agents and antimicrobial management of community-acquired pneumonia in persons aged over 65 years with an emphasis on appropriate antimicrobial therapy for hospitalized elderly patients with community-acquired pneumonia.",
keywords = "Aged, Anti-infective agents, Antibacterial agents, Antibiotics, Pneumonia, Streptococcus pneumoniae",
author = "Velez, {Jose A.} and Mortensen, {Eric M.} and Anzueto, {Antonio R} and Marcos Restrepo",
year = "2006",
month = "12",
doi = "10.2217/1745509X.2.6.999",
language = "English (US)",
volume = "2",
pages = "999--1011",
journal = "Aging Health",
issn = "1745-509X",
publisher = "Future Medicine Ltd.",
number = "6",

}

TY - JOUR

T1 - Antimicrobial treatment of community-acquired pneumonia in the elderly

AU - Velez, Jose A.

AU - Mortensen, Eric M.

AU - Anzueto, Antonio R

AU - Restrepo, Marcos

PY - 2006/12

Y1 - 2006/12

N2 - Community-acquired pneumonia is a clinical diagnosis that has a significant impact on healthcare management around the world, especially in the fastest-growing segment of the population, those aged 65 or older. Early clinical suspicion and prompt empirical antimicrobial therapies are very important in patients with community-acquired pneumonia. This manuscript provides a review of the most recent literature published addressing etiological agents and antimicrobial management of community-acquired pneumonia in persons aged over 65 years with an emphasis on appropriate antimicrobial therapy for hospitalized elderly patients with community-acquired pneumonia.

AB - Community-acquired pneumonia is a clinical diagnosis that has a significant impact on healthcare management around the world, especially in the fastest-growing segment of the population, those aged 65 or older. Early clinical suspicion and prompt empirical antimicrobial therapies are very important in patients with community-acquired pneumonia. This manuscript provides a review of the most recent literature published addressing etiological agents and antimicrobial management of community-acquired pneumonia in persons aged over 65 years with an emphasis on appropriate antimicrobial therapy for hospitalized elderly patients with community-acquired pneumonia.

KW - Aged

KW - Anti-infective agents

KW - Antibacterial agents

KW - Antibiotics

KW - Pneumonia

KW - Streptococcus pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=33845890789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845890789&partnerID=8YFLogxK

U2 - 10.2217/1745509X.2.6.999

DO - 10.2217/1745509X.2.6.999

M3 - Article

AN - SCOPUS:33845890789

VL - 2

SP - 999

EP - 1011

JO - Aging Health

JF - Aging Health

SN - 1745-509X

IS - 6

ER -